Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates

por Polak, Sebastian, Pugsley, Michael K., Stockbridge, Norman, Garnett, Christine, Wiśniowska, Barbara
Publicado 2015

Safety pharmacology during the COVID pandemic

por Pugsley, Michael K., Koshman, Yevgeniya, de Korte, Tessa, Authier, Simon, Curtis, Michael J.
Publicado 2021

Safety pharmacology in 2022: Taking one small step for cardiovascular safety assay development but one giant leap for regulatory drug safety assessment

por Pugsley, Michael K., Koshman, Yevgeniya E., de Korte, Tessa, Authier, Simon, Winters, Brett R., Curtis, Michael J.
Publicado 2022

A pharmacological characterization of Cannabis sativa chemovar extracts

por Devsi, Alykhan, Kiyota, Brett, Ouellette, Theophile, Hegle, Andrew P., Rivera-Acevedo, Ricardo E., Wong, Jasper, Dong, Ying, Pugsley, Michael K., Fung, Timothy
Publicado 2020

Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance

por Vargas, Hugo M, Bass, Alan S, Koerner, John, Matis-Mitchell, Sherri, Pugsley, Michael K, Skinner, Matthew, Burnham, Matthew, Bridgland-Taylor, Matthew, Pettit, Syril, Valentin, Jean-Pierre
Publicado 2015

The Challenges of Predicting Drug-Induced QTc Prolongation in Humans

por Valentin, Jean-Pierre, Hoffmann, Peter, Ortemann-Renon, Catherine, Koerner, John, Pierson, Jennifer, Gintant, Gary, Willard, James, Garnett, Christine, Skinner, Matthew, Vargas, Hugo M, Wisialowski, Todd, Pugsley, Michael K
Publicado 2022